Ignite Creation Date:
2024-05-06 @ 10:40 AM
Last Modification Date:
2024-10-26 @ 12:33 PM
Study NCT ID:
NCT03315299
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-02-07
First Post:
2017-10-16
Brief Title:
Individual Patient Expanded Access Gilteritinib ASP2215
Sponsor:
Etan Orgel
Organization:
Childrens Hospital Los Angeles
Organization Data
Organization:
Childrens Hospital Los Angeles
Class:
OTHER
Study ID:
CHLA-17-00428
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Etan Orgel
Lead Sponsor Class:
OTHER
Responsible Party:
Etan Orgel
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Childrens Hospital Los Angeles
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Astellas Pharma Global Development Inc | INDUSTRY |